知名学者引用


        除了所发表论文的被引用频次、期刊质量能够彰显学者的学术影响力以外,被知名学者引用也是一项学术评价的重要指标。
        当前全球学者库认定的知名学者包括:诺贝尔奖、菲尔兹奖、图灵奖等奖项获得者,多个国家的院士,全球学者库“2023全球学者学术影响力排行版”入榜的前10万学者等。

Xiao, Wei-Kai 中山大学被知名学者引用:150人次(黄金会员以上可以申请导出本人论文被全部知名学者引用的数据)

1. 樊嘉 中国 复旦大学上海医学院 中国科学院院士 Long-term outcomes and prognosis for patients with sarcomatoid hepatocellular carcinoma

2. 郑树森 中国 浙江大学 中国工程院院士 Preoperative risk stratification for early recurrence of HBV-related hepatocellular carcinoma after ..

3. 程书钧 中国 中国医学科学院 中国工程院院士 Post-surgical resection prognostic value of combined OPN, MMP7, and PSG9 plasma biomarkers in hepato..

4. 樊嘉 中国 复旦大学上海医学院 中国科学院院士 A novel and validated prognostic nomogram based on liver fibrosis and tumor burden for patients with..

5. 王红阳 中国 海军军医大学 中国工程院院士 MXR7 facilitates liver cancer metastasis via epithelial-mesenchymal transition

6. 董家鸿 中国 清华大学 中国工程院院士 Prognostic significance of neutrophil-to-lymphocyte ratio in biliary tract cancers: a systematic rev..

7. Califano, Joseph A., Jr. 美国 Partnership to End Addiction 1990美国医学院院士 Neutrophil-to-lymphocyte ratio: Prognostic indicator for head and neck squamous cell carcinoma

8. 董家鸿 中国 清华大学 中国工程院院士 Prognostic Significance of Neutrophil-to-Lymphocyte Ratio in Colorectal Liver Metastasis: A Systemat..

9. 樊嘉 中国 复旦大学上海医学院 中国科学院院士 Positive HBcAb is associated with higher risk of early recurrence and poorer survival after curative..

10. Amaia,Lujambio 美国 Icahn School of Medicine at Mount Sinai The liver cancer immune microenvironment: Therapeutic implications for hepatocellular carcinoma

11. Ingolf,Sack 德国 Charite - Medical University of Berlin Reduced tumor stiffness quantified by tomoelastography as a predicative marker for glypican-3-positi..

12. Andreas,Neubauer 德国 Philipps University of Marburg Rituximab induces a flare-up of activated neutrophil extracellular traps under in vitro conditions

13. 马大青 英国 Imperial College London Predictive value of Leukocyte ImmunoTest (LIT (TM)) in cancer patients: a prospective cohort study

14. Vincenzo,Mazzaferro 意大利 University of Milan Cabozantinib Enhances Anti-PD1 Activity and Elicits a Neutrophil-Based Immune Response in Hepatocell..

15. Josep M,Llovet 美国 New York University Cabozantinib Enhances Anti-PD1 Activity and Elicits a Neutrophil-Based Immune Response in Hepatocell..

16. William M,Lee 美国 University of Texas Southwestern Medical Center High Neutrophil-Lymphocyte Ratio and Delta Neutrophil-Lymphocyte Ratio Are Associated with Increased..

17. Ju Dong,Yang 美国 Cedars-Sinai Medical Center High Neutrophil-Lymphocyte Ratio and Delta Neutrophil-Lymphocyte Ratio Are Associated with Increased..

18. Yujin,Hoshida 美国 ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI High Neutrophil-Lymphocyte Ratio and Delta Neutrophil-Lymphocyte Ratio Are Associated with Increased..

19. Jorge A,Marrero 美国 University of Texas Southwestern Medical Center High Neutrophil-Lymphocyte Ratio and Delta Neutrophil-Lymphocyte Ratio Are Associated with Increased..

20. Amit G,Singal 美国 University of Texas Southwestern Medical Center High Neutrophil-Lymphocyte Ratio and Delta Neutrophil-Lymphocyte Ratio Are Associated with Increased..

全球学者库

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"全球学者库"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前全球学者库共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2023 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3